Powchik Peter Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$40.97M

Insider Activity of Powchik Peter

Biography of Powchik Peter

No biography is available at this moment.

2015-08-14SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
23,485
0.0226%
$573.38$13.47M-27.11%
2015-01-02SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
10,822
0.0107%
$414.08$4.48M+24.89%
2014-01-02SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
20,668
0.021%
$274.77$5.68M+19.4%
2013-12-20SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
133
0.0001%
$271.09$36,055+15.6%
2013-12-18SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
9,000
0.0091%
$270.20$2.43M+17.46%
2013-12-17SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
8
<0.0001%
$270.00$2,160+21.08%
2013-01-03SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clin Devel & Reg Affairs
13,586
0.0141%
$182.11$2.47M+38.83%
2012-12-20SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clin Devel & Reg Affairs
6,623
0.0068%
$170.64$1.13M+41.58%
2012-12-19SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clin Devel & Reg Affairs
10,356
0.011%
$178.50$1.85M+38.91%
2012-11-08SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
15,144
0.0159%
$138.62$2.1M+67%
2012-09-19SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
7,177
0.0076%
$147.16$1.06M+25.57%
2012-07-26SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
7,019
0.0071%
$130.64$916,953+27.77%
2012-02-22SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development & Reg
49,254
0.051%
$96.34$4.75M+39.27%
2011-07-26SaleRegeneron Pharmaceuticals, Inc.
REGN
SVP Clinical Development
10,977
0.0124%
$54.89$602,491+54.88%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.